ClinicalTrials.gg
Active, not recruitingNCT06470867Updated Jun 1, 2026

Randomized Controlled Effectiveness Trial of VA S.A.V.E.

An interventional study of VA S.A.V.E. and Control training in Suicide Prevention, sponsored by VA Office of Research and Development. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
701
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Suicide Prevention by VA Office of Research and Development — 11 open to participants now, 12 under way, none of them phase 3. Suicide Prevention · VA Office of Research and Development.

Enrollment
3rd of 20
701 · median 120
Started
2024
with 1 other
No phase
18 of 20
9 open now
Primary completion
2026-11
later than 0 of 11 live
Registered
12th of 20
by date

Among the 20 studies in Suicide Prevention by VA Office of Research and Development, this one is the 3rd largest by enrollment, is one of 2 that started in 2024, is one of 18 with no phase, reaches primary completion later than 0 of the 11 other live ones, and was the 12th registered.

Suicide Prevention

187 studies on the registry are indexed under Suicide Prevention; 92 are open to participants now.

Browse Suicide Prevention studies →

Open to participants now

11 of the 20 studies in Suicide Prevention by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

6 more — sign in →

By country, each count listing its studies:

All 11 open studies →

Where they have run

Who these studies take

Of the 53 Suicide Prevention studies recruiting now, 28 (53%) set no upper age limit and 21 (40%) stop at 75 or younger; 25 take children under 18; 21 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Suicide Prevention by VA Office of Research and Development, or all of them as a file.
02

Study summary

Veterans are most likely to disclose suicidal thoughts to their close supports such as family and friends. These loved ones are, in turn, very interested in learning how to help a Veteran in need. Close supports are uniquely poised to provide a meaningful contribution to suicide prevention, if they can learn how to effectively promote Veterans' connection to care. VA S.A.V.E. (Signs; Ask; Validate; Encourage) is a suicide prevention gatekeeper training specifically tailored to the Veteran community that teaches close supports how to identify signs of suicide risk and how to connect the at-risk person to professional treatment. The primary objective of this study is to evaluate the effectiveness of VA S.A.V.E. and to explore factors impacting its potential widespread implementation.

Read the detailed description

Background: Levels of help-seeking remain low among Veterans at risk for suicide. Veterans are most likely to disclose suicidal thoughts to close supports-family, friends, caregivers, and peers-who are, in turn, very interested in learning how they might be able to help a Veteran in need. VA S.A.V.E. (Signs; Ask; Validate; Encourage) is a suicide prevention gatekeeper training that can address this opportunity by teaching close supports the skills to identify signs of suicide risk and connect the at-risk Veteran to professional treatment.

Significance: This project evaluates an "upstream" public health approach to suicide prevention that is closely aligned with VA's National Strategy for Preventing Veteran Suicide. Suicide prevention remains VA's top clinical priority, and this project is highly responsive to multiple top VA priorities in research and clinical operations including studies testing outreach strategies to the families of Veterans and conducting clinical trials in suicide prevention.

Innovation \& Impact: Building upon a successful pilot randomized controlled trial of VA S.A.V.E., this randomized controlled effectiveness trial will be the first to rigorously evaluate the effectiveness of VA's signature suicide prevention skills training. Innovations include used of social media and digital outreach for upstream suicide prevention in Veterans not in VA care and use of standardized patient simulation as a method to assess participants' suicide prevention skills.

Specific Aims: The primary objective of this study is to evaluate the effectiveness of VA S.A.V.E. and to explore factors impacting its potential widespread implementation. Specific Aims are: 1) Determine the effectiveness of VA S.A.V.E. in close supports of Veterans; 2) Evaluate mediators and moderators of response to VA S.A.V.E.; and 3) Using qualitative interviews and quantitative survey data, identify barriers to future implementation of VA S.A.V.E. and potential strategies for overcoming them in a diverse sample of close supports of Veterans.

Methodology: The investigators will conduct a randomized controlled effectiveness trial of VA S.A.V.E. using a targeted social media and digital ad campaign to recruit close supports likely to have interactions with Veterans at risk of suicide. Participants (N=710) will be randomized to VA S.A.V.E. versus an informational video (control). The investigators will conduct follow-up surveys over 12 months. The primary outcomes comprise use of gatekeeper behaviors (inquiring about suicidal ideation, recommending professional treatment, and providing suicide prevention hotline information). In a subgroup of participants split equally between treatment arms (n=50), the investigators will also assess suicide prevention skills using a standardized patient simulation. Finally, guided by the Proctor taxonomy as an implementation framework, the investigators will interview a subgroup of participants (n=32-48) to understand their experiences talking about suicide with at-risk Veterans and identify barriers and facilitators to implementation of the training in close supports.

Next Steps/Implementation: The next step in this line of research would be a hybrid type 2 trial (equal focus on effectiveness and implementation). VA S.A.V.E. is free, brief, and accessible training, making it highly amenable to being rapidly taken to scale. Project findings can be used to quickly inform VA social media campaigns and other community-based efforts to disseminate VA S.A.V.E.

03

Conditions studied

  • Suicide Prevention

Keywords

  • Mental Health Services
  • Suicide
  • Education, Distance
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Family member, caregiver, or friend of a Veteran
  • Social contact with a Veteran at least once a week

Exclusion criteria

Exclusion Criteria:

  • Not providing a valid phone number and email address
  • No internet access
  • Indication of duplicate study entry
  • Previously taken, or intending to soon take, VA S.A.V.E. training
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
701 participants (actual)

Study arms

  • Experimental
    Intervention

    VA S.A.V.E. Training

    Behavioral: VA S.A.V.E.

  • Sham comparator
    Control

    Myths and Facts of Wounded Warriors

    Behavioral: Control training

Interventions

  • BehavioralVA S.A.V.E.

    The intervention is called VA S.A.V.E. It is an online video-based training tailored to veterans and their close supports. It is free, brief (24 minutes), and includes three scripted role plays.

  • BehavioralControl training

    An attention control informational video containing information relevant to veterans' mental health but not including elements thought to be "active ingredients" in the intervention.

06

What researchers measure

Primary outcomes

  1. Count of Gatekeeper Behaviors Used

    Number of gatekeeper behaviors used (sum): Gatekeeper behaviors are comprised of three survey items: 1) ask if having suicidal thoughts ("\[In the past month\] how many times did you directly ask a person if they were having suicidal thoughts?"); 2) recommend professional treatment ("How many times did you tell a person having suicidal thoughts to see their doctor, go to the emergency room, call 911, or get any other professional treatment?"); and 3) provide suicide prevention hotline information ("How many times did you give a person having suicidal thoughts information about a suicide prevention hotline such as 988, the Veterans Crisis Line or Military Crisis Line?"). A higher score indicates a better outcome.

    Time frame: 6-month follow-up

Secondary outcomes

  1. Ask if having suicidal thoughts

    Count of Gatekeeper Behavior 1) Ask if having suicidal thoughts. A higher score indicates a better outcome.

    Time frame: 6-month follow-up

  2. Recommend professional treatment

    Count of Gatekeeper Behavior 2) Recommend professional treatment. A higher score indicates a better outcome.

    Time frame: 6-month follow-up

  3. Provide suicide prevention hotline information

    Count of Gatekeeper Behavior 3) Provide suicide prevention hotline information. A higher score indicates a better outcome.

    Time frame: 6-month follow-up

  4. Suicide Prevention Skills

    6-item, coder/clinician-administered scale that assesses: 1) Recognizing Signs of suicide risk; 2) Asking about presence of suicidal thoughts; 3) Validating the Veteran's experience ; 4) Encouraging professional treatment and Expediting getting; 5) Asking about lethal means safety; and 6) empathy/expression of care

    Time frame: 3-month follow-up

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Nov 2026, 24 months after the start.

Of 129 non-industry interventional studies with no phase under Suicide Prevention, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 54. This study's planned 24 months is below that.

Counting every sponsor, half of 131 studies reached it within 28 months; a quarter within 12 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2024
First posted
Jun 24, 2024
StartActual
Nov 21, 2024
Primary completionEst.
Nov 27, 2026
CompletionEst.
May 31, 2027
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06470867
Responsible party
Sponsor
First posted
Jun 24, 2024
Start date
Nov 21, 2024
Primary completion
Nov 27, 2026 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Jun 1, 2026

Study contacts

Alan R. Teo, MD MS
principal investigator · VA Portland Health Care System, Portland, OR

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion